Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 4
2009 6
2010 11
2011 11
2012 12
2013 9
2014 6
2015 5
2016 9
2017 10
2018 11
2019 11
2020 8
2021 9
2022 9
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD.
Jarasvaraparn C, Vilar-Gomez E, Yates KP, Wilson LA, Neuschwander-Tetri B, Loomba R, Cummings O, Vos M, Xanthakos S, Schwimmer J, Molleston JP, Sanyal A, Tonascia J, Chalasani N. Jarasvaraparn C, et al. Clin Gastroenterol Hepatol. 2024 May;22(5):1024-1036.e2. doi: 10.1016/j.cgh.2023.12.009. Epub 2023 Dec 23. Clin Gastroenterol Hepatol. 2024. PMID: 38145725
Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
Wang A, Blackford AL, Behling C, Wilson LA, Newton KP, Xanthakos SA, Fishbein MH, Vos MB, Mouzaki M, Molleston JP, Jain AK, Hertel P, Harlow Adams K, Schwimmer JB; NASH CRN. Wang A, et al. Hepatology. 2023 Oct 23:10.1097/HEP.0000000000000644. doi: 10.1097/HEP.0000000000000644. Online ahead of print. Hepatology. 2023. PMID: 37870272
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis.
Sanyal AJ, Shankar SS, Yates KP, Bolognese J, Daly E, Dehn CA, Neuschwander-Tetri B, Kowdley K, Vuppalanchi R, Behling C, Tonascia J, Samir A, Sirlin C, Sherlock SP, Fowler K, Heymann H, Kamphaus TN, Loomba R, Calle RA. Sanyal AJ, et al. Nat Med. 2023 Oct;29(10):2656-2664. doi: 10.1038/s41591-023-02539-6. Epub 2023 Sep 7. Nat Med. 2023. PMID: 37679433 Free PMC article.
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance.
Gill RM, Allende D, Belt PH, Behling CA, Cummings OW, Guy CD, Carpenter D, Neuschwander-Tetri BA, Sanyal AJ, Tonascia J, Van Natta ML, Wilson LA, Yamada G, Yeh M, Kleiner DE; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN). Gill RM, et al. Hepatol Commun. 2023 Feb 1;7(2):e0033. doi: 10.1097/HC9.0000000000000033. eCollection 2023 Feb 1. Hepatol Commun. 2023. PMID: 36724127 Free PMC article.
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis.
Sanyal A, Shankar S, Yates K, Bolognese J, Daly E, Dehn C, Neuschwander-Tetri B, Kowdley K, Vuppalanchi R, Behling CA, Tonascia J, Samir A, Sirlin C, Sherlock S, Fowler K, Heymann H, Kamphaus T, Loomba R, Calle R. Sanyal A, et al. Res Sq [Preprint]. 2023 Jan 19:rs.3.rs-2492725. doi: 10.21203/rs.3.rs-2492725/v1. Res Sq. 2023. PMID: 36711803 Free PMC article. Updated. Preprint.
Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease.
Sanyal AJ, Williams SA, Lavine JE, Neuschwander-Tetri BA, Alexander L, Ostroff R, Biegel H, Kowdley KV, Chalasani N, Dasarathy S, Diehl AM, Loomba R, Hameed B, Behling C, Kleiner DE, Karpen SJ, Williams J, Jia Y, Yates KP, Tonascia J. Sanyal AJ, et al. J Hepatol. 2023 Apr;78(4):693-703. doi: 10.1016/j.jhep.2022.11.029. Epub 2022 Dec 14. J Hepatol. 2023. PMID: 36528237 Free PMC article. Clinical Trial.
Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis.
Shen W, Middleton MS, Cunha GM, Delgado TI, Wolfson T, Gamst A, Fowler KJ, Alazraki A, Trout AT, Ohliger MA, Shah SN, Bashir MR, Kleiner DE, Loomba R, Neuschwander-Tetri BA, Sanyal AJ, Zhou J, Sirlin CB, Lavine JE. Shen W, et al. J Hepatol. 2023 Feb;78(2):238-246. doi: 10.1016/j.jhep.2022.10.027. Epub 2022 Nov 8. J Hepatol. 2023. PMID: 36368598 Free PMC article. Clinical Trial.
Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
Newton KP, Wilson LA, Crimmins NA, Fishbein MH, Molleston JP, Xanthakos SA, Behling C, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network. Newton KP, et al. Clin Gastroenterol Hepatol. 2023 May;21(5):1261-1270. doi: 10.1016/j.cgh.2022.05.028. Epub 2022 Jun 13. Clin Gastroenterol Hepatol. 2023. PMID: 35709934 Free PMC article.
Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children.
Goyal NP, Rosenthal SB, Nasamran C, Behling CA, Angeles JE, Fishbein MH, Harlow KE, Jain AK, Molleston JP, Newton KP, Ugalde-Nicalo P, Xanthankos SA, Yates K, Schork NJ, Fisch KM, Schwimmer JB; NASH Clinical Research Network. Goyal NP, et al. Hepatology. 2023 Jan 1;77(1):197-212. doi: 10.1002/hep.32570. Epub 2022 Jun 20. Hepatology. 2023. PMID: 35560106 Free PMC article.
111 results